Terapia de combinación secuencial con prednisona, lamivudina e interferón alfa-2b en pacientes con hepatitis crónica B y antígeno e positivo

Virologic response was clinically, but not statistically, superior in the group with prednisone priming. Histologic improvement was notable in the group with previous immunosuppression.